Home Kolaviron ameliorates chronic unpredictable mild stress-induced anxiety and depression: involvement of the HPA axis, antioxidant defense system, cholinergic, and BDNF signaling
Article
Licensed
Unlicensed Requires Authentication

Kolaviron ameliorates chronic unpredictable mild stress-induced anxiety and depression: involvement of the HPA axis, antioxidant defense system, cholinergic, and BDNF signaling

  • Ismail O. Ishola EMAIL logo , Taiwo G. Olubodun-Obadun , Oluwasayo A. Bakre , Emmanuel S. Ojo and Olufunmilayo O. Adeyemi
Published/Copyright: February 24, 2022

Abstract

Objectives

This study sought to investigate the beneficial effect of kolaviron (KV) (a biflavonoid) isolated from Garcinia kola seed on chronic unpredictable mild stress (CUMS)-induced anxiety- and depressive-like behavior.

Methods

Male albino mice were randomly divided into six groups (n=8) as follows; Group I: vehicle-control unstressed; Group II: CUMS-control; Group III-V: CUMS + KV 1, 5 or 50 mg/kg, respectively, Group VI: KV (50 mg/kg, p.o.) unstressed mice. Animals were subjected to CUMS for 14 days, followed by estimation of depressive- and anxiety-like behavior from days 14–16. This was followed by biochemical assays for oxidative stress, hypothalamo-pituitary axis, cholinergic, and BDNF signaling.

Results

CUMS caused significant reduction in time spent in open arms of elevated plus maze test (EPM) and increase in immobility time in tail suspension test (TST) and forced swim test (FST) ameliorated by KV treatments. KV administration also attenuated CUMS-induced malondialdehyde/nitrite generation and decrease in antioxidant enzymes activities in the prefrontal cortex and hippocampus. CUMS increased serum corticosterone, acetylcholinesterase activity, and reduced BDNF level in the PFC and hippocampus were attenuated by KV administration.

Conclusions

KV prevented CUMS induced anxiety- and depression-like behavior in mice through enhancement of antioxidant defense mechanisms, neurotrophic factors, and cholinergic systems.


Corresponding author: Ismail O. Ishola, PhD, Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, Lagos State, Nigeria; and African Centre of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science, Lagos, Nigeria, E-mail:

Acknowledgments

Authors are grateful to Mr. Chijioke C.M. of the Department of Pharmacology, Therapeutics and Toxicology and Mr. S.A. Adenekan of the Department of Biochemistry, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, for their technical assistance.

  1. Research funding: None declared.

  2. Author contributions: IOI, OOT, and OAB conceived and designed the study, IOI and OAB conducted experiments. IOI, ESO, and OOA analyzed data and wrote the manuscript. All authors read and approved the manuscript. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: Ethical approval (CMUL/HREC/11/17/267) for this study was obtained from the Health Research Ethics Committee of the College of Medicine, University of Lagos.

References

1. Woelfer, M, Kasties, V, Kahlfuss, S, Walter, M. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience 2019;403:93–110. https://doi.org/10.1016/j.neuroscience.2018.03.034.Search in Google Scholar PubMed

2. Patel, D, Kas, MJ, Chattarji, S, Buwalda, B. Rodent models of social stress and neuronal plasticity: relevance to depressive-like disorders. Behav Brain Res 2019;369:111900. https://doi.org/10.1016/j.bbr.2019.111900.Search in Google Scholar PubMed

3. Seo, D, Ahluwalia, A, Potenza, MN, Sinha, R. Gender differences in neural correlates of stress-induced anxiety. J Neurosci Res 2017;95:115–25. https://doi.org/10.1002/jnr.23926.Search in Google Scholar PubMed PubMed Central

4. Tata, DA, Anderson, BJ. The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression. Physiol Behav 2010;99:186–93. https://doi.org/10.1016/j.physbeh.2009.09.008.Search in Google Scholar PubMed PubMed Central

5. Shepard, R, Coutellier, L. Changes in the prefrontal glutamatergic and parvalbumin systems of mice exposed to unpredictable chronic stress. Mol Neurobiol 2018;55:2591–602. https://doi.org/10.1007/s12035-017-0528-0.Search in Google Scholar PubMed

6. Salim, S. Oxidative stress and the central nervous system. J Pharmacol Exp Therapeut 2017;360:201–5. https://doi.org/10.1124/jpet.116.237503.Search in Google Scholar PubMed PubMed Central

7. Ahmad, A, Rasheed, N, Ashraf, GM, Kumar, R, Banu, N, Khan, F, et al.. Brain region specific monoamine and oxidative changes during restraint stress. Can J Neurol Sci 2012;39:311–8. https://doi.org/10.1017/s0317167100013433.Search in Google Scholar PubMed

8. Yazir, Y, Utkan, T, Şahin, TD, Gocmez, SS. Improvement of penile neurogenic and endothelial relaxant responses by chronic administration of resveratrol in rabbits exposed to unpredictable chronic mild stress. Int J Impot Res 2018;30:163–70. https://doi.org/10.1038/s41443-018-0016-8.Search in Google Scholar PubMed

9. Hu, M, Zou, W, Wang, CY, Chen, X, Tan, HY, Zeng, HY, et al.. Hydrogen sulfide protects against chronic unpredictable mild stress-induced oxidative stress in Hippocampus by upregulation of BDNF-TrkB pathway. Oxid Med Cell Longev 2016;2016:2153745. https://doi.org/10.1155/2016/2153745.Search in Google Scholar PubMed PubMed Central

10. Borrow, AP, Heck, AL, Miller, AM, Sheng, JA, Stover, SA, Daniels, RM, et al.. Chronic variable stress alters hypothalamic-pituitary-adrenal axis function in the female mouse. Physiol Behav 2019;209:112613. https://doi.org/10.1016/j.physbeh.2019.112613.Search in Google Scholar PubMed PubMed Central

11. Yang, XH, Song, SQ, Xu, Y. Resveratrol ameliorates chronic unpredictable mild stress-induced depression-like behavior: involvement of the HPA axis, inflammatory markers, BDNF, and Wnt/β-catenin pathway in rats. Neuropsychiatric Dis Treat 2017;13:2727–36. https://doi.org/10.2147/ndt.s150028.Search in Google Scholar PubMed PubMed Central

12. Herman, JP, McKlveen, JM, Ghosal, S, Kopp, B, Wulsin, A, Makinson, R, et al.. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol 2016;6:603–21. https://doi.org/10.1002/cphy.c150015.Search in Google Scholar PubMed PubMed Central

13. Yang, D, Li, Q, Fang, L, Cheng, K, Zhang, R, Zheng, P, et al.. Reduced neurogenesis and pre-synaptic dysfunction in the olfactory bulb of a rat model of depression. Neuroscience 2011;192:609–18. https://doi.org/10.1016/j.neuroscience.2011.06.043.Search in Google Scholar PubMed

14. Naqvi, F, Saleem, S, Naqvi, F, Batool, Z, Sadir, S, Tabasumm, S, et al.. Curcumin lessens unpredictable chronic mild stress-induced depression and memory deficits by modulating oxidative stress and cholinergic activity. Pak J Pharm Sci 2019;32:1893–900.Search in Google Scholar

15. Colomer, C, Olivos-Oré, LA, Vincent, A, McIntosh, JM, Artalejo, AR, Guérineau, NC. Functional characterization of alpha9-containing cholinergic nicotinic receptors in the rat adrenal medulla: implication in stress-induced functional plasticity. J Neurosci 2010;30:6732–42. https://doi.org/10.1523/jneurosci.4997-09.2010.Search in Google Scholar PubMed PubMed Central

16. Pavlovsky, L, Bitan, Y, Shalev, H, Serlin, Y, Friedman, A. Stress-induced altered cholinergic-glutamatergic interactions in the mouse hippocampus. Brain Res 2012;1472:99–106. https://doi.org/10.1016/j.brainres.2012.05.057.Search in Google Scholar PubMed

17. Shen, J, Xu, L, Qu, C, Sun, H, Zhang, J. Resveratrol prevents cognitive deficits induced by chronic unpredictable mild stress: sirt1/miR-134 signalling pathway regulates CREB/BDNF expression in hippocampus in vivo and in vitro. Behav Brain Res 2018;349:1–7. https://doi.org/10.1016/j.bbr.2018.04.050.Search in Google Scholar PubMed

18. Lu, Y, Ho, CS, McIntyre, RS, Wang, W, Ho, RC. Effects of vortioxetine and fluoxetine on the level of Brain Derived Neurotrophic Factors (BDNF) in the hippocampus of chronic unpredictable mild stress-induced depressive rats. Brain Res Bull 2018;142:1–7. https://doi.org/10.1016/j.brainresbull.2018.06.007.Search in Google Scholar PubMed

19. Akinmoladun, AC, Akinrinola, BL, Olaleye, MT, Farombi, EO. Kolaviron, a Garcinia kola biflavonoid complex, protects against ischemia/reperfusion injury: pertinent mechanistic insights from biochemical and physical evaluations in rat brain. Neurochem Res 2015;40:777–87. https://doi.org/10.1007/s11064-015-1527-z.Search in Google Scholar PubMed

20. Olajide, OJ, Asogwa, NT, Moses, BO, Oyegbola, CB. Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats. Metab Brain Dis 2017;32:1147–61. https://doi.org/10.1007/s11011-017-0012-6.Search in Google Scholar PubMed

21. Ishola, IO, Adamson, FM, Adeyemi, OO. Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system. Metab Brain Dis 2017;32:235–45. https://doi.org/10.1007/s11011-016-9902-2.Search in Google Scholar PubMed

22. Ishola, IO, Awodele, O, Eluogu, CO. Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action. J Compl Integr Med 2016;13:275–87. https://doi.org/10.1515/jcim-2015-0047.Search in Google Scholar

23. Gawali, NB, Bulani, VD, Gursahani, MS, Deshpande, PS, Kothavade, PS, Juvekar, AR. Agmatine attenuates chronic unpredictable mild stress-induced anxiety, depression-like behaviours and cognitive impairment by modulating nitrergic signalling pathway. Brain Res 2017;1663:66–77. https://doi.org/10.1016/j.brainres.2017.03.004.Search in Google Scholar

24. Ishola, IO, Akinyede, AA, Sholarin, AM. Antidepressant and anxiolytic properties of the methanolic extract of Momordica charantia Linn (Cucurbitaceae) and its mechanism of action. Drug Res 2014;64:368–76. https://doi.org/10.1055/s-0033-1358712.Search in Google Scholar

25. Lowry, OH, Rosebrough, NJ, Farr, AL, Randall, RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75. https://doi.org/10.1016/s0021-9258(19)52451-6.Search in Google Scholar

26. Ishola, IO, Tota, S, Adeyemi, OO, Agbaje, EO, Narender, T, Shukla, R. Protective effect of Cnestis ferruginea and its active constituent on scopolamine-induced memory impairment in mice: a behavioral and biochemical study. Pharm Biol 2013;51:825–35. https://doi.org/10.3109/13880209.2013.767360.Search in Google Scholar

27. Willner, P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997;134:319–29. https://doi.org/10.1007/s002130050456.Search in Google Scholar

28. Hill, MN, Hellemans, KG, Verma, P, Gorzalka, BB, Weinberg, J. Neurobiology of chronic mild stress: parallels to major depression. Neurosci Biobehav Rev 2012;36:2085–117. https://doi.org/10.1016/j.neubiorev.2012.07.001.Search in Google Scholar

29. Belzung, C, Griebel, G. Measuring normal and pathological anxiety‐like behaviour in mice: a review. Behav Brain Res 2001;125:141–9. https://doi.org/10.1016/s0166-4328(01)00291-1.Search in Google Scholar

30. Zhang, C, Kalueff, AV, Song, C. Minocycline ameliorates anxiety-related self-grooming behaviors and alters hippocampal neuroinflammation, GABA and serum cholesterol levels in female Sprague–Dawley rats subjected to chronic unpredictable mild stress. Behav Brain Res 2019;363:109–17. https://doi.org/10.1016/j.bbr.2019.01.045.Search in Google Scholar PubMed

31. Smaga, I, Niedzielska, E, Gawlik, M, Moniczewski, A, Krzek, J, Przegaliński, E, et al.. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Pharmacol Rep 2015;67:569–80. https://doi.org/10.1016/j.pharep.2014.12.015.Search in Google Scholar PubMed

32. Moniczewski, A, Gawlik, M, Smaga, I, Niedzielska, E, Krzek, J, Przegaliński, E, et al.. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorers. Part 1. Chemical aspects and biological sources of oxidative stress in the brain. Pharmacol Rep 2015;67:560–8. https://doi.org/10.1016/j.pharep.2014.12.014.Search in Google Scholar PubMed

33. Saricicek, A, Esterlis, I, Maloney, KH, Mineur, YS, Ruf, BM, Muralidharan, A, et al.. Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder. Am J Psychiatr 2012;169:851–9. https://doi.org/10.1176/appi.ajp.2012.11101546.Search in Google Scholar PubMed PubMed Central

34. Risch, SC, Cohen, RM, Janowsky, DS, Kalin, NH, Sitaram, N, Gillin, JC, et al.. Physostigmine induction of depressive symptomatology in normal human subjects. Psychiatr Res 1981;4:89–94. https://doi.org/10.1016/0165-1781(81)90012-3.Search in Google Scholar

35. Das, A, Rai, D, Dikshit, M, Palit, G, Nath, C. Nature of stress: differential effects on brain acetylcholinesterase activity and memory in rats. Life Sci 2005;77:2299–311. https://doi.org/10.1016/j.lfs.2005.02.020.Search in Google Scholar PubMed

36. Biala, G, Pekala, K, Boguszewska-Czubara, A, Michalak, A, Kruk-Slomka, M, Budzynska, B. Behavioral and biochemical interaction between nicotine and chronic unpredictable mild stress in mice. Mol Neurobiol 2017;54:904–21. https://doi.org/10.1007/s12035-016-9701-0.Search in Google Scholar PubMed PubMed Central

37. Mineur, YS, Obayemi, A, Wigestrand, MB, Fote, GM, Calarco, CA, Li, AM, et al.. Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior. Proc Natl Acad Sci U S A 2013;110:3573–8. https://doi.org/10.1073/pnas.1219731110.Search in Google Scholar PubMed PubMed Central

38. de Andrade, JS, Céspedes, IC, Abrão, RO, Dos Santos, TB, Diniz, L, Britto, LR, et al.. Chronic unpredictable mild stress alters an anxiety-related defensive response, Fos immunoreactivity and hippocampal adult neurogenesis. Behav Brain Res 2013;250:81–90. https://doi.org/10.1016/j.bbr.2013.04.031.Search in Google Scholar PubMed

39. Krugers, HJ, Goltstein, PM, van der Linden, S, Joëls, M. Blockade of glucocorticoid receptors rapidly restores hippocampal CA1 synaptic plasticity after exposure to chronic stress. Eur J Neurosci 2006;23:3051–5. https://doi.org/10.1111/j.1460-9568.2006.04842.x.Search in Google Scholar PubMed

40. Calabrese, F, Molteni, R, Racagni, G, Riva, MA. Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 2009;34:S208–16. https://doi.org/10.1016/j.psyneuen.2009.05.014.Search in Google Scholar PubMed

41. Martinowich, K, Manji, H, Lu, B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007;10:1089–93. https://doi.org/10.1038/nn1971.Search in Google Scholar PubMed

42. Banerjee, R, Ghosh, AK, Ghosh, B, Bhattacharyya, S, Mondal, AC. Decreased mRNA and protein expression of BDNF, NGF, and their receptors in the Hippocampus from suicide: an analysis in human postmortem brain. Clin Med Insights Pathol 2013;6:1–11. https://doi.org/10.4137/CMPath.S12530.Search in Google Scholar PubMed PubMed Central

43. Paska, AV, Zupanc, T, Pregelj, P. The role of brain-derived neurotrophic factor in the pathophysiology of suicidal behavior. Psychiatr Danub 2013;25:S341–4.Search in Google Scholar

44. Koo, JW, Chaudhury, D, Han, MH, Nestler, EJ. Role of mesolimbic brain-derived neurotrophic factor in depression. Biol Psychiatr 2019;86:738–48. https://doi.org/10.1016/j.biopsych.2019.05.020.Search in Google Scholar PubMed PubMed Central

45. Lu, B. BDNF and activity-dependent synaptic modulation. Learn Mem 2003;10:86–98. https://doi.org/10.1101/lm.54603.Search in Google Scholar PubMed PubMed Central

46. Zu, X, Zhang, M, Li, W, Xie, H, Lin, Z, Yang, N, et al.. Antidepressant-like effect of bacopaside I in mice exposed to chronic unpredictable mild stress by modulating the hypothalamic-pituitary-adrenal axis function and activating BDNF signaling pathway. Neurochem Res 2017;42:3233–44. https://doi.org/10.1007/s11064-017-2360-3.Search in Google Scholar PubMed

Received: 2020-12-24
Revised: 2021-06-12
Accepted: 2021-08-11
Published Online: 2022-02-24

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Reviews
  3. Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines
  4. Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics
  5. Original Articles
  6. Predicting drug–drug interactions by electrochemically driven cytochrome P450 3A4 reactions
  7. Evaluation of the stability of furosemide in tablet form during six-month storage in spaceflight and peculiarities of its pharmacokinetics and pharmacodynamics under conditions of anti-orthostatic hypokinesia
  8. CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers
  9. The markers of the organic acidemias and their ratios in healthy neonates in Serbian population
  10. Kolaviron ameliorates chronic unpredictable mild stress-induced anxiety and depression: involvement of the HPA axis, antioxidant defense system, cholinergic, and BDNF signaling
  11. The efficacy of topical Marham-e-Akbar in chronic atopic dermatitis – an open-label interventional study
  12. In vitro metabolic biomodulation of irinotecan to increase potency and reduce dose-limiting toxicity by inhibition of SN-38 glucuronide formation
  13. Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity
  14. Synergistic anti-cancer effects of Nigella sativa seed oil and conventional cytotoxic agent against human breast cancer
  15. Short Communication
  16. MTHFR c.665C>T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements
Downloaded on 24.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dmpt-2021-0125/html
Scroll to top button